Market Overview:
The global gynecology devices market size reached US$ 12.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 12.8 Billion |
Market Forecast in 2032
|
US$ 23.1 Billion |
Market Growth Rate (2024-2032) |
6.6% |
Gynecology devices are used to treat conditions associated with the female reproductive system. These devices assist in performing colposcopy, loop tubal ligation, endometrial biopsy, ovarian cystectomy, electrical excision procedure (LEEP), intrauterine device (IUD) insertion, and dilation and curettage (D&C). Some of the widely used gynecology devices are forceps and clamps for caesarian delivery, cervical dilators for stretching the cervical muscles, and punch forceps for premalignant lesions of the cervix. Recent advances in lasers have escalated the demand for gynecology devices across the globe to treat cysts, endometriosis, genital warts, fibroid tumors, abnormal uterine bleeding, ectopic pregnancy, and urinary incontinence.
Gynecology Devices Market Trends:
A significant rise in the number of women with gynecological conditions, such as cervical cancer, vaginal melanoma, extended bleeding, irregular menstrual cycles, and polycystic ovary syndrome, represents one of the primary factors fueling the market growth. Moreover, growing awareness about the benefits of regular check-ups is influencing the market positively. The emerging trend of minimally invasive (MI) procedures and increasing utilization of imaging devices like three-dimensional (3D) endoscopes is also contributing to the market growth. Apart from this, several manufacturers are investing in research and development (R&D) activities to develop efficient devices that can provide accurate and quick diagnoses and minimize operating time. This, in confluence with the rising need for durable and easy autoclavable surgical instruments, is bolstering the market growth. Furthermore, health authorities of numerous countries are focusing on increasing the number of hospitals for gynecology and improving the services in existing ones. This is anticipated to drive the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gynecology devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product and end use.
Breakup by Product:
- Surgical Devices
- Gynecological Endoscopy Devices
- Hysteroscope
- Colposcope
- Resectoscope
- Laparoscope
- Endoscopic Imaging Systems
- Endometrial Ablation Devices
- Hydrothermal Ablation Devices
- Radiofrequency Ablation Devices
- Balloon Ablation Devices
- Others
- Fluid Management Systems
- Female Sterilization/Contraceptive Devices
- Permanent Birth Control
- Intra Uterine Devices (IUD)
- Intravaginal Rings
- Subdermal Contraceptive Implants
- Hand Instruments
- Vaginal Speculum
- Tenaculum
- Curettes
- Trocars
- Biopsy Forceps
- Others
- Others
Breakup by End Use:
- Hospitals and Clinics
- Diagnostic Centers
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CooperSurgical Inc., Fresenius Medical Care AG & Co. KGAA, General Electric Company, Hologic Inc., Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens AG and Stryker Corporation.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Product, End Use, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Boston Scientific Corporation, CooperSurgical Inc., Fresenius Medical Care AG & Co. KGAA, General Electric Company, Hologic Inc., Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens AG and Stryker Corporation. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global gynecology devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global gynecology devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global gynecology devices market and who are the key players?
- What is the degree of competition in the industry?